Pfizer selects once-daily GLP-1 for its obesity push Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category but has now decided on a lead candidate
Among the biggest firms (those with at least 5,000 workers), 43% now say they cover GLP-1 drugs for weight loss in their largest plan, up from 28% in 2024
100 mg Other Ingredients: Methylcellulose Capsule, Codeage Helix Liposomal Delivery (providing phospholipids from non-GMO sunflower lecithin, including phosphatidylcholine), Microcrystalline Cellulose
(naturally occurring acetylates/amidated form)
Here are five potential side effects that some patients may experience, most of which are mild and temporary: Mild Injection Site Discomfort Some people may feel slight redness, swelling, or soreness at the injection site, which usually resolves quickly